Abstract

Research Article

SARS-CoV-2 Omicron and centaurus variants induced lymphocytopenia: A multicenter clinical investigation on 118,561 cases across Pakistan during 2021-2022

Rizwan Uppal, Muhammad Saad Uppal, Aftab Ahmad Khan and Umar Saeed*

Published: 16 September, 2022 | Volume 6 - Issue 2 | Pages: 034-037

The SARS-CoV-2 pandemic is still ongoing. Previously, several studies have been conducted to investigate laboratory markers as a tool for severity assessment during COVID-19 infections. Biological markers such as Platelet count, D-dimer and IL-6, Lymphocytopenia and others have been used for assessment of severity in COVID-19 disease patients (infected by SARS-CoV-2 Alpha, Beta, Gamma, Delta, Epsilon, and other variants). We observed a significant drop in lymphocyte count among suspected SARS-CoV-2 clinical patients with symptoms of fever, running nose, breathing discomfort, cough, and others during Omicron and Centaurus variants spread in Pakistan. A multicenter, cross-sectional study was conducted from Jan 2021 to Aug 2022, on 118,561 subjects to evaluate hematological abnormalities among suspected patients. Of note, significantly decreased lymphocyte levels (lymphocytopenia) were observed among 43.05% of infected patients. Also, the levels of NA (39.03%), HGB (28.27%), MCV (22.62%), PLT (8.17%), and ALB (4.30%) were also reduced among infected patients. This suggests that lymphopenia can be used as an alternative, cost-effective, early diagnostic biomarker for clinical COVID-19 patients, even before the diagnosis via real-time PCR. In resource-limited countries, the current study is critical for policy-making strategic organizations for prioritizing lymphocytopenia-based screening (as an alternative, cost-effective diagnostic test) in clinical COVID-19 patients, before real-time PCR-based diagnosis.

Read Full Article HTML DOI: Cite this Article Read Full Article PDF

Keywords:

SARS-CoV-2; Omicron; Centaurus; Lymphopenia; Biomarkers; Pakistan

References

  1. World Health Organization. Coronavirus disease (COVID-19) outbreak 2022. https://www.who.int/westernpacific/emergencies/covid-19.
  2. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 79. World Heal. Organ. 2020.
  3. woldometers.info/coronavirus/
  4. Saeed U, Uppal SR, Piracha ZZ, Rasheed A, Aftab Z, Zaheer H, Uppal R. Evaluation of SARS-CoV-2 antigen-based rapid diagnostic kits in Pakistan: formulation of COVID-19 national testing strategy. Virol J. 2021 Feb 13;18(1):34. doi: 10.1186/s12985-021-01505-3. PMID: 33581714; PMCID: PMC7881305. https://doi.org/10.1186/s12985-021-01505-3.
  5. https://covid.gov.pk/
  6. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Apr 6;: PMID: 32125452; PMCID: PMC7080116.
  7. Lin L, Lu L, Cao W, Li T. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020 Dec;9(1):727-732. doi: 10.1080/22221751.2020.1746199. PMID: 32196410; PMCID: PMC7170333.
  8. Li T, Qiu Z, Zhang L, Han Y, He W, Liu Z, Ma X, Fan H, Lu W, Xie J, Wang H, Deng G, Wang A. Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome. J Infect Dis. 2004 Feb 15;189(4):648-51. doi: 10.1086/381535. Epub 2004 Feb 4. PMID: 14767818; PMCID: PMC7109946.
  9. Raj VS, Mou H, Smits SL, Dekkers DH, Müller MA, Dijkman R, Muth D, Demmers JA, Zaki A, Fouchier RA, Thiel V, Drosten C, Rottier PJ, Osterhaus AD, Bosch BJ, Haagmans BL. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013 Mar 14;495(7440):251-4. doi: 10.1038/nature12005. PMID: 23486063; PMCID: PMC7095326.
  10. Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020 Feb 24;12(1):8. doi: 10.1038/s41368-020-0074-x. PMID: 32094336; PMCID: PMC7039956.
  11. Saeed U, Uppal SR, Piracha ZZ, Uppal R. COVID-19 Transmission via Fomites at Low Temperature: A Potential Silent SARS-CoV-2 Propagation Route. Am J Biomed Sci & Res. 2021 - 12(1)? AJBSR.MS.ID.001716.
  12. Saeed U, Uppal SR, Piracha ZZ, Khan AA, Rasheed A, Zaheer H, et al. Effectivity analysis of SARS-CoV-2 nasopharyngeal swab rapid testing kits in Pakistan: A scenario of inadequate COVID-19 diagnosis. Research Square. 2021; Doi: 10.21203/rs.3.rs-315851/v1.
  13. Saeed U, Manzoor S. Risk factors associated with transmission of hepatitis B and hepatitis C virus in Pakistan. Glob J Med Res. 2014; 14(1):14–9.
  14. Saeed U, Waheed Y, Ashraf M. Hepatitis B and hepatitis C viruses: a review of viral genomes, viral induced host immune responses, genotypic distributions and worldwide epidemiology. Asian Pac J Trop Dis. 2014; 4(2):88–96. Doi: 10.1016/s2222-1808(14)60322-4.
  15. Saeed U, Waheed Y, Ashraf M, Waheed U, Anjum S, Afzal MS. Estimation of hepatitis B virus, hepatitis C virus, and different clinical parameters in the thalassemia population of capital twin cities of Pakistan. Virology (Auckl). 2015; 6:11–6. Doi: 10.4137/VRT.S31744.
  16. Saeed U, Rizwan Uppal S, Zahid Piracha Z, Uppal R. Azithromycin treatment for SARS-CoV-2-related COVID-19 pandemic could worsen extensively drug resistant XDR typhoid: A risk of losing the last bullet against Salmonella enteric serovar typhi. Jundishapur J Microbiol. 2021; 14(1). e113874. Doi: 10.5812/jjm.113874.
  17. Saeed U, Uppal SR, Piracha ZZ, Uppal R. COVID-19 transmission via fomites at low temperature: A potential silent SARS-CoV-2 propagation route. Am J Biomed Sci & Res. 2021; 12(1):80–2.
  18. Saeed U, Uppal SR, Piracha ZZ, Uppal R. SARS-CoV-2 Spike Antibody Levels Trend among Sinopharm Vaccinated People. Iran J Public Health. 2021; Jul50(7):1486-1487. doi: 10.18502/ijph.v50i7.6640. PMID: 34568189; PMCID: PMC8426791.
  19. Saeed U, Uppal SR, Piracha ZZ, Khan AA, Rasheed A, Waheed A. Evaluation of SARS-CoV-2 spike antibody levels among Sputnik V first dose vaccinated people in Pakistan: formulation of national anti COVID-19 mass vaccination strategy. Res Sq. 2021; Doi: 10.21203/rs.3.rs480406/v1.
  20. Saeed U, Piracha ZZ, Uppal R, Uppal R. SARS-CoV-2-Associated CRP, DD, FER, HBA1c, IL6, LDH, PBNP, and PCT Biomarkers and High-Resolution Computed Tomography During the First Three Waves of COVID-19 in Pakistan 2019-2021. Jundishapur J Microbiol. 2022; 15(1):e119590.
  21. Uppal SR, Khan AA, Saeed U, Piracha ZZ. Dermatomycoses in Pakistan; an urgent need for National Surveillance Programs. Ann Dermatol Res. 2022; 6: 014-016.

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More